PerkinElmer Receives Clearance for Two Assays

The FDA granted 510(k) clearance for two new PerkinElmer assays developed by its Euroimmun subsidiary.

The assays screen and diagnose anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, disorders that can be hard to diagnose.

The two assays provide reliable ANCA screening results and eliminate the need to run several analyses for each sample.